Biology Education

Daniel is Co-Chairman of Intellectual Property Group at Adler Pollock & Sheehan. P.C. He has extensive experience in developing and executing honest and straightforward strategies for clients' intellectual property portfolios with a sharply honed focus on furthering their business objectives. As a registered patent attorney with the United States Patent and Trademark Office, Daniel has a passionate focus on assisting a wide range of clients from early stage technology companies to Fortune 500 companies located throughout the United States and Canada with their intellectual property law issues. More specifically, Daniel advocates and counsels clients in intellectual property areas such as patents, trademarks, copyrights, trade secrets, unfair competition, and domain names. Daniel's range of technology areas is vast including medical devices, software, biofuels, nanotechnology, material science, eyewear, coatings, vaccines, chemicals, consumer packaging, biotechnology, and green technologies. 

Daniel advises on all aspects of intellectual property protection including prosecution, procurement, federal litigation, proceedings before the Patent and Trial Appeal Board (PTAB) (i.e. reexaminations and interferences), Trademark Trial and Appeals Board (TTAB) (i.e. oppositions, cancellations, appeals), reexamination, interference, Uniform Domain-Name Dispute Resolution Policy (UDRP) proceedings, licensing from technology transfer offices and others, and auctioning of IP. Furthermore, he is a registered patent attorney with the U.S. Patent Office and admitted to the federal district courts in Rhode Island and Massachusetts. He received his BA in business administration from UMass Amherst and his JD from Temple University’s James E. Beasley School of Law. Daniel teaches BIOL 2089 The Importance of Intellectual Property in Biotechnology.